RecruitingNCT07605481

Dumping Syndrome After Esophagectomy

Prospective Observational Study on the Utility of Continuous Glucose Monitoring for the Diagnosis of Dumping Syndrome After Esophagectomy


Sponsor

Samsung Medical Center

Enrollment

30 participants

Start Date

Jun 15, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Background: Dumping syndrome is a common complication for patients who have undergone surgery for esophageal cancer. It occurs when food moves too quickly from the stomach (or the reconstructed gastric tube) into the small intestine. This rapid movement causes various symptoms such as bloating, abdominal pain, dizziness, rapid heartbeat, and sweating. Sometimes, it leads to "late dumping," where blood sugar levels drop significantly, causing tremors, cold sweats, and fatigue. Currently, there is no standardized tool to easily diagnose this condition after esophagectomy. Purpose of the Study: The objective of this study is to evaluate the effectiveness of Continuous Glucose Monitoring (CGM) in diagnosing dumping syndrome. CGM is a small, wearable sensor that tracks glucose levels in real-time. The investigators aim to determine whether CGM can serve as a valuable tool for the early detection of dumping syndrome in patients who have undergone esophagectomy.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • aged 18 or older. 2. people who underwent esophagectomy and gastric tube reconstruction for esophageal cancer.
  • \. Sigstad score of 7 or higher.

Exclusion Criteria1

  • \. Diabetes with autonomic neuropathy. 2. Inability to complete the diagnostic procedure (e.g., cognitive decline). 3. Refusal to participate.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Samsung Medical Center

Seoul, Gangnam-gu Irwon-Ro 81, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07605481


Related Trials